Accelerate Diagnostics Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures

Reuters

2025/05/13

<a href="https://laohu8.com/S/AXDX">Accelerate Diagnostics</a> Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures

Accelerate Diagnostics Inc. recently announced that it faces delisting from the Nasdaq Stock Market following its voluntary Chapter 11 bankruptcy filing on May 8, 2025. The company received a delisting notice from Nasdaq, citing public interest concerns related to the bankruptcy, as well as the company's failure to meet the minimum bid price and market value requirements. The company's stock, which has consistently closed below the $1.00 per share threshold, will be suspended from trading on Nasdaq starting May 15, 2025, and is expected to transition to the over-the-counter market under the symbol "AXDXQ." However, there is no guarantee that the shares will begin or continue trading in the OTC market. Accelerate Diagnostics Inc. does not plan to appeal the delisting decision.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accelerate Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-047314), on May 12, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2535292781"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535292781\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535292781?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-13 04:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535292781","market":"us","top_or_hot":-1,"title":"Accelerate Diagnostics Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AXDX\">Accelerate Diagnostics</a> Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Accelerate Diagnostics Inc. recently announced that it faces delisting from the Nasdaq Stock Market following its voluntary Chapter 11 bankruptcy filing on May 8, 2025. The company received a delisting notice from Nasdaq, citing public interest concerns related to the bankruptcy, as well as the company's failure to meet the minimum bid price and market value requirements. The company's stock, which has consistently closed below the $1.00 per share threshold, will be suspended from trading on Nasdaq starting May 15, 2025, and is expected to transition to the over-the-counter market under the symbol \"AXDXQ.\" However, there is no guarantee that the shares will begin or continue trading in the OTC market. Accelerate Diagnostics Inc. does not plan to appeal the delisting decision.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accelerate Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-047314), on May 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Accelerate Diagnostics Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAccelerate Diagnostics Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-13 04:17</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AXDX\">Accelerate Diagnostics</a> Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Accelerate Diagnostics Inc. recently announced that it faces delisting from the Nasdaq Stock Market following its voluntary Chapter 11 bankruptcy filing on May 8, 2025. The company received a delisting notice from Nasdaq, citing public interest concerns related to the bankruptcy, as well as the company's failure to meet the minimum bid price and market value requirements. The company's stock, which has consistently closed below the $1.00 per share threshold, will be suspended from trading on Nasdaq starting May 15, 2025, and is expected to transition to the over-the-counter market under the symbol \"AXDXQ.\" However, there is no guarantee that the shares will begin or continue trading in the OTC market. Accelerate Diagnostics Inc. does not plan to appeal the delisting decision.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accelerate Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-047314), on May 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AXDXQ","symbol_name":"Accelerate Diagnostics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL5bkpgX:1","article_id":"2535292781","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535292781","pubTimestamp":1747081029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Accelerate Diagnostics Inc. recently announced that it faces delisting from the Nasdaq Stock Market following its voluntary Chapter 11 bankruptcy filing on May 8, 2025. The company received a delisting notice from Nasdaq, citing public interest concerns related to the bankruptcy, as well as the company's failure to meet the minimum bid price and market value requirements. The company's stock, which has consistently closed below the $1.00 per share threshold, will be suspended from trading on Nasdaq starting May 15, 2025, and is expected to transition to the over-the-counter market under the symbol \"AXDXQ.\" However, there is no guarantee that the shares will begin or continue trading in the OTC market. Accelerate Diagnostics Inc. does not plan to appeal the delisting decision.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AXDXQ":"Accelerate Diagnostics, Inc.","AXDX":"Accelerate Diagnostics","BK4082":"医疗保健设备"},"translate_title":"Accelerate Diagnostics Inc.因申请破产和合规失败而面临从纳斯达克退市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AXDX":0.9,"AXDXQ":0.9},"content_text":"Accelerate Diagnostics Inc. Faces Delisting from Nasdaq Following Bankruptcy Filing and Compliance Failures\n    \n\n        Accelerate Diagnostics Inc. recently announced that it faces delisting from the Nasdaq Stock Market following its voluntary Chapter 11 bankruptcy filing on May 8, 2025. The company received a delisting notice from Nasdaq, citing public interest concerns related to the bankruptcy, as well as the company's failure to meet the minimum bid price and market value requirements. The company's stock, which has consistently closed below the $1.00 per share threshold, will be suspended from trading on Nasdaq starting May 15, 2025, and is expected to transition to the over-the-counter market under the symbol \"AXDXQ.\" However, there is no guarantee that the shares will begin or continue trading in the OTC market. Accelerate Diagnostics Inc. does not plan to appeal the delisting decision.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accelerate Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-047314), on May 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}